This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2 May 2012

Mergers & Acquisitions Activity 'Lower Than Expected' in 2011

The latest report from BioWorld reveals that M&A activity was more subdued than expected in 2011, while the number of biopharmaceutical collaborations declined.

There were more mergers and acquisitions (M&As) among biopharmaceutical companies in 2011 than in 2010, but activity was still weaker than expected, a new report suggests.


The 'BioWorld Biotechnology State of the Industry Report 2012' reveals that M&A activity increased in 2011, with the value of deals also rising.


But industry observers had been anticipating a greater number of deals than actually materialised.


Jennifer Boggs, managing editor of BioWorld, suggested that last year's activity came across a backdrop of "slower-than-expected M&A trends in 2010".


"Hopes were high going into 2011, but

Related News